Stifel Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
|
|||||
|
2025
Q1 | $2.78M | Buy |
|
|||||
|
2024
Q4 | $2.1M | Buy |
|
|||||
|
2024
Q3 | $2.15M | Sell |
|
|||||
|
2024
Q2 | $3.62M | Buy |
|
|||||
|
2024
Q1 | $3.83M | Sell |
|
|||||
|
2023
Q4 | $4.79M | Buy |
|
|||||
|
2023
Q3 | $4M | Buy |
|
|||||
|
2023
Q2 | $3.31M | Sell |
|
|||||
|
2023
Q1 | $3.8M | Sell |
|
|||||
|
2022
Q4 | $4.52M | Buy |
|
|||||
|
2022
Q3 | $3.56M | Buy |
|
|||||
|
2022
Q2 | $3.27M | Sell |
|
|||||
|
2022
Q1 | $3.55M | Sell |
|
|||||
|
2021
Q4 | $11.5M | Sell |
|
|||||
|
2021
Q3 | $10.8M | Sell |
|
|||||
|
2021
Q2 | $13.6M | Sell |
|
|||||
|
2021
Q1 | $12.3M | Sell |
|
|||||
|
2020
Q4 | $15.5M | Buy |
|
|||||
|
2020
Q3 | $12.9M | Buy |
|
|||||
|
2020
Q2 | $18.6M | Sell |
|
|||||
|
2020
Q1 | $13.6M | Buy |
|
|||||
|
2019
Q4 | $10.8M | Buy |
|
|||||
|
2019
Q3 | $8.25M | Buy |
|
|||||
|
2019
Q2 | $8.82M | Buy |
|
|||||
|
2019
Q1 | $6.36M | Buy |
|
|||||
|
2018
Q4 | $3.95M | Buy |
|
|||||
|
2018
Q3 | $3.89M | Buy |
|
|||||
|
2018
Q2 | $3.35M | Buy |
|
|||||
|
2018
Q1 | $755K | Buy |
|
|||||
|
2017
Q4 | $382K | Sell |
|
|||||
|
2017
Q3 | $470K | Sell |
|
|||||
|
2017
Q2 | $539K | Buy |
|
|||||
|
2017
Q1 | $452K | Sell |
|
|||||
|
2016
Q4 | $617K | Buy |
|
|||||
|
2016
Q3 | $568K | Buy |
|
|||||
|
2016
Q2 | $292K | Sell |
|
|||||
|
2016
Q1 | $420K | Buy |
|
|||||
|
2015
Q4 | $366K | Buy |
|